Stocks / NASDAQ / Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated

Our Opinion

Ligand Pharmaceuticals Incorporated is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.

“The new study describes a nonsteroidal compound that attaches to testosterone receptors in cells and triggers the same desired effects as actual testosterone, in tests in laboratory animals.” Read the following article

Company Description

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. [Source: MarketWatch]

Company Website: